EDN1 and cancer: Among Roquin2 targets, we chose four angiogenic genes (ENG, EDN1, VEGFB, and PDGFC) based on two criteria: 1) they are commonly downregulated in different types of cancer cells; and 2) they are among the most affected genes by Roquin2.